Novo Nordisk A/S reported DKK1.03T in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
Novo Nordisk A/S DKK 1.03T 421.31B Mar/2026
Pacira USD 915M 149M Mar/2026
Sanofi EUR 100.27B 605.48M Mar/2026
Supernus Pharmaceuticals USD 2.98B 126M Mar/2026